{
    "clinical_study": {
        "@rank": "30232", 
        "arm_group": [
            {
                "arm_group_label": "Shock wave tratment", 
                "arm_group_type": "Active Comparator", 
                "description": "Shock waves are applied extracorporealy"
            }, 
            {
                "arm_group_label": "Placebo Shock wave treatment", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Shock waves are prohibited to enter the body by placebo stand-off"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the pilot study is to assess the feasibility of a full randomised,\n      placebo-controlled clinical trial.The aim is to demonstrate that penile shockwave\n      application in patients with erectile dysfunction of vascular origin leads to a greater\n      increase in potency than in the control group."
        }, 
        "brief_title": "Pilot Study of the Treatment of Erectile Dysfunction With Extracorporeal Shockwave Therapy (ESWT)", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Erectile Dysfunction", 
        "condition_browse": {
            "mesh_term": "Erectile Dysfunction"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Erectile dysfunction for more than 6 months\n\n          -  Informed consent\n\n          -  Positive effect of PDE-5-Hammer\n\n          -  IIEF-15 score less than 20\n\n          -  No neurological desease\n\n          -  Stable partnership for more than 3 months\n\n          -  Age 18-75\n\n        Exclusion Criteria:\n\n          -  Total prostatectomy\n\n          -  Another reason for DE except for vascular disorder\n\n          -  Clinically significant hematological desease\n\n          -  Heart stroke, Arrythmia during the last 6 months\n\n          -  Cancer dureing tha last 5 years\n\n          -  Intake of antiandrogen\n\n          -  ED treatment with the last 7 days\n\n          -  IIEF score higher than, equal to 20\n\n          -  Previous shockwave treatment"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02068417", 
            "org_study_id": "STU10/002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Shock wave tratment", 
                "description": "shockwaves are applied extracorporealy with 0.1mJ/mm2", 
                "intervention_name": "shock waves", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Placebo Shock wave treatment", 
                "description": "shock waves are applied extracoporealy with 0.1mJ/mm2 through placebo stand-off which prohibits the shock waves to enter the body", 
                "intervention_name": "placebo shockwave traetment", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "IIEF score", 
        "lastchanged_date": "February 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chemnitz", 
                    "country": "Germany"
                }, 
                "name": "Bethanien Krankenhaus Chemnitz gemeinn\u00fctzige GmbH"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomised, Blinded, Placebo-controlled Pilot Study of the Treatment of Erectile Dysfunction With Extracorporeal Shockwave Therapy (ESWT)", 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": [
                "Austria: Federal Office for Safety in Health Care", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Pakistan: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Effects of erection problems on the sex life (International Index of Erectile Function Questionnaire)", 
            "safety_issue": "No", 
            "time_frame": "up to 6 months post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02068417"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Quality of erection (Quality of Erection Questionnaire)", 
            "safety_issue": "No", 
            "time_frame": "At screening, 1, 3 and 6 months post treatment"
        }, 
        "source": "Storz Medical AG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Storz Medical AG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014", 
        "why_stopped": "It has been decided to improve the inclusion criteria for better study outcome"
    }
}